Medical/Pharmaceuticals
$412.5 million! Mabwell Announces Exclusive Licensing Agreement with DISC MEDICINE, INC. for Innovative Drug Candidates of Hematologic Diseases
SAN DIEGO, Jan. 19, 2023 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with the layout of whole industry chain, announced its wholly-owned subsidiary Mabwell Therapeutics has entered into an agreement with DISC MEDICINE, INC. ("Disc") about 9MW3011 (R&D code in t...
2023-01-20 09:50
3301
NEW THERAPY TO TREAT RARE GASTROINTESTINAL STROMAL TUMOUR APPROVED FOR NEW ZEALAND PATIENTS
* QINLOCK® (ripretinib) now Medsafe approved for GIST patients in NZ * QINLOCK now being considered by PHARMAC for reimbursement * Data from the INVICTUS Phase 3 study shows QINLOCK reduces risk of disease progression or death by 85%1, 2 SINGAPORE and AUCKLAND, New Zealand, Jan. 19, 2023 /PR...
2023-01-20 02:00
3244
Hepagene Therapeutics Reports Positive Top-line Results for Phase 2a RISE Study of FXR Agonist HPG1860 in Patients with NASH
SHANGHAI, Jan. 19, 2023 /PRNewswire/ -- Hepagene Therapeutics, Inc. a clinical stage biopharmaceutical company focusing on developing novel therapies for patients with chronic liver diseases, today reported positive top-line results from the Phase 2a RISE clinical trial of HPG1860, a next gene...
2023-01-19 23:00
3247
Zhongchao Inc. Launches Medication Management Assistance Mini Program to Facilitate Cancer Treatment
SHANGHAI, Jan. 19, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services to patients with oncology and other major diseases, today announced that Zhongxin Medical Technology Co., Ltd. ("Zhongxin"), one of ...
2023-01-19 20:30
3193
Tigermed Completes Acquisition of Marti Farm
HANGZHOU, China and ZAGREB, Croatia, Jan. 19, 2023 /PRNewswire/ -- Tigermed (300347.SZ/3347.HK), a leading global provider of clinical research solutions across the full lifecycle of global biopharmaceutical and medical device products, announced today the completion of its acquisition of Marti F...
2023-01-19 14:59
5678
China's First and Only Approved Third-Generation BCR-ABL Inhibitor Olverembatinib Included into the 2022 National Reimbursement Drug List
SUZHOU, China, and ROCKVILLE, MD, Jan. 18, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, and Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), today an...
2023-01-19 11:45
3079
Lunit Highlights the Effectiveness of AI in Predicting Cancer Treatment Outcomes - Findings to be Presented at ASCO GI 2023
* Lunit to present two abstracts featuring Lunit SCOPE IO, the company's AI biomarker for immune phenotyping * Lunit's presentations this year will highlight the effectiveness of Lunit SCOPE IO as a biomarker to predict treatment outcomes in liver and colon cancer SEOUL, South Korea, Jan. 18,...
2023-01-18 21:00
2748
Keymed Biosciences | The Latest Results from the Phase Ia Clinical Study of CMG901 was presented at the 2023 ASCO GI CANCERS SYMPOSIUM
CHENGDU, China, Jan. 17, 2023 /PRNewswire/ -- Keymed Biosciences Inc. (Stock Code: 02162 HK) is pleased to announce that the latest data from the Phase Ia dose-escalation trial of CMG901 (Claudin 18.2 antibody drug conjugate), a novel drug candidate, for advanced solid tumors will be presented as...
2023-01-18 09:52
2931
IASO Bio Raises Nearly $75 Million in Series C1 Funding
Approaches Commercialization of First Product NANJING and SHANGHAI, China and SAN JOSE, Calif., Jan. 17, 2023 /PRNewswire/ -- IASO Biotherapeutics (IASO Bio), a clinical-stage biopharmaceutical company engaged in discovering, developing, and manufacturing innovative cell therapies and antibody p...
2023-01-18 08:00
3272
Asieris Appoints Dr. Linda Wu as Chief Development Officer
SHANGHAI, Jan. 17, 2023 /PRNewswire/ -- Asieris Pharmaceuticals(688176.SH), a global biopharma company specializing in discovering, developing and commercializing innovative drugs for the treatment of genitourinary tumors and other related diseases, announced thatLinda Wu, Ph.D. will join Asieris...
2023-01-18 07:00
3014
Tanso Biosciences Expands Its Line-up with 250 Mouse GPCRs
TOKYO, Jan. 17, 2023 /PRNewswire/ -- Tanso Biosciences, a leading provider of functional assays for G-protein-coupled receptors (GPCRs), is thrilled to announce a major expansion of its assay platform. Building upon its already extensive coverage of 300 human GPCRs, Tanso Biosciences has added 25...
2023-01-18 00:00
2600
Hybribio returns to Medlab Middle East 2023
GUANGZHOU, China, Jan. 17, 2023 /PRNewswire/ -- Medlab Middle East 2023 will be held at the World Trade Centre,Dubai, UAE from February 6 to 9. As one of the most well-known and professional exhibitions of trade platforms for the field of medical laboratory equipment and medical equipment, this e...
2023-01-17 22:30
3619
Health supplement information app Pillwork set for launch in the first-half year
SEOUL, South Korea, Jan. 17, 2023 /PRNewswire/ -- Pillwork releases its app
Pillwork that allows people to easily compare and purchase health supplements
in the first-half year.
2023-01-17 15:03
2053
Organon Is Recognized as Both "Top Employers China 2023" And "Best Workplaces™ in Greater China 2022"
SHANGHAI, Jan. 17, 2023 /PRNewswire/ -- Today, Organon China is proud to have been named the "2023 Top Employers inChina" and honored to receive "Best Workplaces™ inGreater China 2022" certificate, in recognizing its vision-driven company culture, diversity and inclusion, strong employer brand, a...
2023-01-17 13:06
2446
Full-Life Technologies Announces Appointment of Steffen Heeger, MD, PhD, as Chief Medical Officer and Fa Liu, PhD, as Chief Scientific Officer
MANNHEIM, Germany, WATCHUNG, N.J. and SHANGHAI, Jan. 16, 2023 /PRNewswire/ -- Full-Life Technologies today announced the appointments ofSteffen Heeger, MD, PhD, as Chief Medical Officer (CMO) and Fa Liu, PhD as Chief Scientific Officer (CSO). Dr. Heeger has held senior oncology clinical developme...
2023-01-17 10:00
2814
FDA Accepts GMP Plasmid DMF of OBiO Technology
SHANGHAI, Jan. 16, 2023 /PRNewswire/ -- OBiO Technology (Shanghai) Corp., Ltd. ('OBiO', 688238.SH), a gene and cell therapy-focused contract research organization (CRO) and contract development and manufacturing organization (CDMO), recently announced that the United States Food and Drug Administ...
2023-01-17 08:00
3215
FAPON presents at 41st Annual J.P. Morgan Healthcare Conference
SHENZHEN, China, Jan. 16, 2023 /PRNewswire/ -- FAPON, a leading life sciences company, announced that Mr. Jielun ZHU, the company's Chief Financial Officer (CFO) and Chief Investment Officer (CIO), has presented at the 41st Annual J.P. Morgan Healthcare Conference and shared FAPON's development, ...
2023-01-16 22:09
4478
CARsgen Therapeutics and Huadong Medicine Announce Collaboration Agreement For Zevorcabtagene Autoleucel In Mainland China
SHANGHAI, Jan. 16, 2023 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, andHuadong Medicine ( Hangzhou) Co., Ltd., a wholly-owned subsidiary of Huadong Medicine Co....
2023-01-16 18:00
3388
Medtech Innovator magAssist Inc. Gains Recognition for Its Innovation in the Cardiovascular Field at 2022 Critical Heart Disease Congress-International Society for Mechanical Circulatory Support Parallel Forum
SUZHOU, China, Jan. 16, 2023 /PRNewswire/ -- magAssist Inc. ("magAssist"), a leading global developer of extracorporeal life support devices, attended the 2022 Critical Heart Disease Congress - International Society for Mechanical Circulatory Support Parallel Forum, where the firm shared the late...
2023-01-16 17:25
4487
SD Biosensor Successfully Finishes JP Morgan Healthcare Conference
* Entering the US market in earnest by acquiring Meridian * Expanding into a direct sales system in 10 countries within the year * Launching plans, including the new product, 'STANDARD M10 FAST RT-PCR, CGMS' SEOUL, South Korea, Jan. 13, 2023 /PRNewswire/ -- SD Biosensor, Inc. (KS137310), Sou...
2023-01-13 15:11
3517
Week's Top Stories
Most Reposted
SMU School of Accountancy launches Applied AI Track for next generation of accounting and finance professionals
[Picked up by 282 media titles]
2026-10-07 11:50DayOne Files Registration Statement for Proposed Initial Public Offering
[Picked up by 279 media titles]
2026-10-06 05:28Agoda Partners with Marina Bay Sands on Bespoke Flagship Store for Experience-Led Travel
[Picked up by 277 media titles]
2026-10-08 09:50
New Asia Forum Targets US$30 Billion in Investment into the New Asia at Its Inaugural Edition in Bali
[Picked up by 274 media titles]
2026-10-09 13:21The Coffee Bean & Tea Leaf® Turns 63 and Sets a New Direction for Its Next Chapter of Growth
[Picked up by 263 media titles]
2026-10-05 13:24
Most Read
Nuix Neo Generative AI Framework
2026-10-08 08:02
9180
DayOne Files Registration Statement for Proposed Initial Public Offering
2026-10-06 05:28
8293
Silicon Quantum Computing Named to Fast Company's 2026 Next Big Things in Tech List
2026-10-06 19:38
8265
